In cancer cells, disorders of PD-L1 expression and its binding to PD-1 of cytotoxic T cells act as a “stop sign” and counter the proliferation and function of T cells, thus augmenting the tumor evasion of host antitumor immunity. Here, CD274 is linked to cancer.